A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 4,114,125 shares of VNDA stock, worth $20.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,114,125
Previous 4,275,625 3.78%
Holding current value
$20.7 Million
Previous $17.6 Million 32.27%
% of portfolio
0.04%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$3.91 - $6.5 $631,465 - $1.05 Million
-161,500 Reduced 3.78%
4,114,125 $23.2 Million
Q1 2024

May 13, 2024

BUY
$3.47 - $4.61 $2.06 Million - $2.74 Million
594,500 Added 16.15%
4,275,625 $17.6 Million
Q4 2023

Feb 13, 2024

BUY
$3.38 - $4.58 $1.4 Million - $1.9 Million
415,100 Added 12.71%
3,681,125 $15.5 Million
Q3 2023

Nov 14, 2023

BUY
$4.28 - $6.57 $658,940 - $1.01 Million
153,958 Added 4.95%
3,266,025 $14.1 Million
Q2 2023

Aug 11, 2023

BUY
$5.9 - $6.95 $1.04 Million - $1.23 Million
176,842 Added 6.02%
3,112,067 $20.5 Million
Q1 2023

May 12, 2023

BUY
$6.18 - $7.99 $283,044 - $365,942
45,800 Added 1.59%
2,935,225 $19.9 Million
Q4 2022

Feb 13, 2023

SELL
$6.87 - $10.96 $2.79 Million - $4.45 Million
-405,808 Reduced 12.32%
2,889,425 $21.4 Million
Q3 2022

Nov 14, 2022

SELL
$9.44 - $11.76 $3.22 Million - $4.01 Million
-341,200 Reduced 9.38%
3,295,233 $32.6 Million
Q2 2022

Aug 12, 2022

BUY
$9.31 - $11.84 $3.98 Million - $5.07 Million
427,819 Added 13.33%
3,636,433 $39.6 Million
Q1 2022

May 13, 2022

SELL
$10.84 - $16.55 $39,024 - $59,580
-3,600 Reduced 0.11%
3,208,614 $36.3 Million
Q4 2021

Feb 11, 2022

SELL
$15.69 - $21.14 $1.1 Million - $1.48 Million
-70,108 Reduced 2.14%
3,212,214 $50.4 Million
Q3 2021

Nov 12, 2021

SELL
$15.35 - $21.27 $439,010 - $608,322
-28,600 Reduced 0.86%
3,282,322 $56.3 Million
Q2 2021

Aug 13, 2021

SELL
$15.71 - $21.51 $5.9 Million - $8.08 Million
-375,558 Reduced 10.19%
3,310,922 $71.2 Million
Q1 2021

May 13, 2021

SELL
$13.42 - $20.28 $4.08 Million - $6.16 Million
-303,923 Reduced 7.62%
3,686,480 $55.4 Million
Q4 2020

Feb 10, 2021

SELL
$9.77 - $13.81 $3.82 Million - $5.39 Million
-390,519 Reduced 8.91%
3,990,403 $52.4 Million
Q3 2020

Nov 13, 2020

BUY
$9.32 - $12.02 $1.41 Million - $1.82 Million
151,100 Added 3.57%
4,380,922 $42.3 Million
Q2 2020

Aug 13, 2020

BUY
$9.66 - $12.02 $3.67 Million - $4.57 Million
380,168 Added 9.88%
4,229,822 $48.4 Million
Q1 2020

May 14, 2020

BUY
$7.5 - $16.8 $2.97 Million - $6.66 Million
396,542 Added 11.48%
3,849,654 $39.9 Million
Q4 2019

Feb 13, 2020

BUY
$12.38 - $17.47 $3.03 Million - $4.28 Million
244,772 Added 7.63%
3,453,112 $56.7 Million
Q3 2019

Nov 13, 2019

BUY
$12.27 - $15.79 $5.03 Million - $6.48 Million
410,290 Added 14.66%
3,208,340 $42.6 Million
Q2 2019

Aug 12, 2019

BUY
$13.37 - $18.85 $3.12 Million - $4.4 Million
233,300 Added 9.1%
2,798,050 $39.4 Million
Q1 2019

May 14, 2019

BUY
$17.59 - $31.05 $939,306 - $1.66 Million
53,400 Added 2.13%
2,564,750 $47.2 Million
Q4 2018

Feb 13, 2019

BUY
$18.97 - $31.47 $47.6 Million - $79 Million
2,511,350 New
2,511,350 $65.6 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $284M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.